Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Female

Explore clinical trials studying Genital Neoplasms, Female. Study availability and eligibility vary by location and protocol.

4,586 public trials 1,038 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Female trial results

Recruiting

A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

NCT06515613

Conditions
Endocrine Gland Neoplasms, Endocrine System Diseases, Endometrial Cancer, +20 more
Locations
  • University of Arkansas Winthrop P. Rockefeller Cancer Institute Little Rock, Arkansas, United States
  • Precision NextGen Oncology & Research Center Beverly Hills, California, United States
  • SCRI at Denver Health Denver, Colorado, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 14 locations
View Trial Details
Recruiting

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

NCT05548296

Conditions
Endometrial Adenocarcinoma, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Alaska Women's Cancer Center Anchorage, Alaska, United States
  • HonorHealth Phoenix, Arizona, United States
  • Arizona Oncology Associate, PC- HOPE Tucson, Arizona, United States
View all 91 locations
View Trial Details
Recruiting

A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression

NCT06365853

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations
  • University of California Los Angeles /ID# 269339 Los Angeles, California, United States
  • Norton Cancer Institute - St. Matthews /ID# 269070 Louisville, Kentucky, United States
  • Holy Cross Hospital - Silver Spring /ID# 269344 Silver Spring, Maryland, United States
  • Mercy David C. Pratt Cancer Center /ID# 269350 St Louis, Missouri, United States
View all 40 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

NCT06051695

Conditions
Adenoma, Adnexal Diseases, Bronchial Neoplasms, +61 more
Locations
  • Banner Health Gilbert, Arizona, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Stanford University Stanford, California, United States
View Trial Details

Related conditions